Genomics and large scale phenotypic databases.
Progress in the development of molecular genetic tools and in sequencing the human genome will accelerate the understanding of complex genetic diseases. However, phenotypic clinical data needs to be obtained and recorded to a similar degree of precision in order to match the wealth of molecular genetic data. To achieve this goal, large scale phenotypic databases of complex genetic diseases are under construction. LURIC (the LUwigshafen Risk and Cardiovascular Health Study) is such a project, aiming to identify new genetic and environmental risk factors or markers for cardiovascular disease in order to better understand the pathophysiology of complex genetic disease. It should also allow the determination of the prognostic role of new markers by studying functional genomics, (the association between a gene variant and phenotype), and pharmacogenomics (the influence of genetic variation on the response to therapeutic agents).
Winkelmann
B R
BR
Heart Centre Ludwigshafen, Cardiovascular Molecular Genetics Laboratory, Bremser Str. 79, Ludwigshafen, D-67063, Germany. winkbr@gmx.de
D002318:Cardiovascular Diseases / Q000235:genetics*; D016208:Databases, Factual; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics; D005819:Genetic Markers; D014644:Genetic Variation; D005828:Genetics, Population; D015894:Genome, Human; D023281:Genomics; D006801:Humans; D006973:Hypertension / Q000235:genetics; D010597:Pharmacogenetics; D010641:Phenotype
D005819:Genetic Markers